El glioblastoma multiforme es el subtipo mas comun y mas letal de gliomas, cuya incidencia se describe entre 0,6 a 3,7 por 100.000 personas, siendo el tercer tipo tumoral mas frecuentemente reportado, luego de los meningiomas y los tumores pituitarios (Gousias et al., 2009; Lee et al., 2010; Dobes et al., 2011; Gigineishvili et al., 2013; Ostrom et al., 2013), considerado uno de los tumores mas letales en humanos (Dunn et al., 2012).
M2 PRESSWIRE-August 23, 2019-: Global Glioblastoma Multiforme Treatment Market Estimated to grow With a CAGR of 11% During the Forecast Period, 2019-2024
Release date- 20082019 - New research by Sussex scientists could be the first step towards developing a blood test to diagnose the most aggressive type of brain tumour, known as Glioblastoma.
THURSDAY, June 27, 2019 (HealthDay News) -- The percentage of patients achieving five-year survival following a glioblastoma diagnosis remains both steady and low, according to a study published online June 19 in Mayo Clinic Proceedings.
Global Banking News-June 12, 2019-MetVital awarded US FDA clearance of IND Application for AEO for Phase 2 testing of brain cancer Glioblastoma Multiforme
The-37-year-old, who is from Akpugo in Nkanu West Local Government Area of Enugu State, won the award with his research work on 'Anti-PD-L1 Immunotherapy Enhances Radiation-induced Abscopal Response in Glioblastoma'.
Patent and Trademark Office for a pending patent application which covers MN-166, or ibudilast, for the treatment of glioblastoma. Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than December 2037.
CINCINNATI, Ohio, April 11, 2019 -- Cell-by-cell genetic analyses of developing brain tissues in neonatal mice and laboratory models of brain cancer allowed scientists to discover a molecular driver of the highly aggressive, deadly, and treatment-resistant brain cancer, glioblastoma.
Spurred by Tessa's effort, a landmark trial has opened for people with glioblastoma at the National Hospital for Neurology and Neurosurgery in Central London.
By boosting drug distribution using the new approach, the scientists were able to double the median survival period of mice with glioblastoma to 80 days.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.